Recalls this week include high chairs, cribs, bar stools, bicycles, and various electronics
High chairs that can potentially entrap a child and poses a strangulation hazard are among this week's recalled consumer products.
Obama administration proposes to ban health discrimination against transgender individuals
The Obama administration says it wants to end discrimination against transgender people throughout the health care system.
Mallinckrodt skids after cutting forecast for Acthar, the target of $5.6B acquisition in 2014
Shares of Mallinckrodt slid 12 percent Tuesday after the Irish drugmaker reported disappointing quarterly revenue and said growth in sales of its HP Acthar Gel, the target of a $5.6 billion acquisition last year, may be lower than it expected.
Aluminum-sided Ford F-150 gets mixed crash test results from insurance industry
Ford's aluminum-sided F-150 pickup saw mixed results in new crash tests.
Gilead Sciences 2Q profit jumps 23 pct., tops Street views, propelled by hepatitis C medicines
Blockbuster hepatitis C medicine Harvoni lifted Gilead Sciences' second-quarter profit by 23 percent as total revenue for the biotech drugmaker jumped 26 percent and it raised its 2015 sales forecast for the second time.
Glance: A snapshot of the new 'Big Three' of health insurance
Anthem Inc.'s $48 billion purchase of rival Cigna Corp. is set to create the nation's largest health insurance company.
UnitedHealth Group beats 2Q earnings and revenue expectations
UnitedHealth Group Inc. (UNH) on Thursday reported second-quarter net income of $1.59 billion.
Insurer Aetna to buy Humana in $37B deal to create 2nd-largest managed-care company
Health insurer Aetna Inc. has made a deal to buy competitor Humana Inc. in a $37 billion deal the companies say would create the second-largest managed care company.
Health insurance acquisition spree leaves heaps of uncertainty for consumers
More than a third of the U.S. population has health coverage through an insurer that either wants to make a huge acquisition or is about to be swallowed up in one.
Business Highlights
___ US probing possible airline collusion that kept fares high WASHINGTON (AP) — The U.S. government is investigating possible collusion among major airlines to limit available seats, which keeps airfares high, according to a document obtained by The Associated Press.
Health insurance stocks climb early, as merger talk centers on possible Anthem-Cigna combo
Major health insurers are trading higher before the opening bell Monday after Anthem went public with a bid to buy Cigna for about $47 billion and a report of another major acquisition surfaced.
Anthem stands by its $47-billion offer for Cigna despite rival insurer's rejection of the bid
Anthem says it still backs an approximately $47-billion bid to buy Cigna, a day after the rival health insurer delivered a caustic rejection of Anthem's proposed cash-and-stock offer.
Anthem proposes to buy Cigna for $184 per share
U.S. health insurer Anthem Inc. is making an offer to buy rival Cigna Corp. for $54 billion, including debt.
Another round of deal reports spurs jump for several health insurer stocks
The shares of some major health insurers are climbing on a down day for the broader market after The Wall Street Journal reported that the Blue Cross-Blue Shield carrier Anthem tried to buy Cigna.
Only 3 of 7 midsize SUVs perform well in insurance industry front crash tests for 2015 models
Only three of seven midsize SUVs from the 2015 model year performed well in front-end crash tests done by an insurance industry group.
Aetna targets LGBT community as insurers seek ways to market more to individual customers
Aetna is urging gay customers to "be proud" — and consider buying its coverage — as part of a new, narrow focus to selling health insurance in a business where the individual's buying decision matters more than it used to.
A glance at some of the insurers wrestling with nursing-home bills
Life insurance firms used to pitch long-term care policies as the prudent way for Americans to shoulder the cost of staying in nursing homes.
FDA approval of Novartis drug opens door to lower-cost biotech medicines in US
Federal health officials say they approved the first lower-cost copy of a biotech drug, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.
Obama administration unveils plan to shift Medicare payments, rewarding quality vs. quantity
The Obama administration is unveiling what it calls a historic shift in the way Medicare pays hospitals and doctors.
Consumer group sues Aetna, says mail-order drug policy discriminates against people with HIV
A consumer advocacy group has filed a class-action lawsuit against Aetna Inc. saying a new policy violates the privacy of people with HIV and AIDS by requiring them to get their medications from its mail-order pharmacy.